【摘 要】
:
Objective: Breast carcinoma classification has dramatically changed in recent years following application of molecular techniques.Immunohistochemistry can help select patients for diferent therapies.T
【机 构】
:
Obstetrics & Gynaecology Hospital Infanta Cristina Spain
【出 处】
:
(BITs 3rd Annual World Cancer Congress-2010, Breast Cancer C
论文部分内容阅读
Objective: Breast carcinoma classification has dramatically changed in recent years following application of molecular techniques.Immunohistochemistry can help select patients for diferent therapies.The objective of the present report is to determine the prognostic influence of the molecular classifcation of breast carcinoma with immunohistochemistry.Materials and Methods: We have retrospectively selected a cohort of 257 patients with invasive ductal carcinoma NOS diagnosed and treated in the same hospital between 1997 and 2000.We have classifed the cases in four tumor types according to the immunohistochemical expression of several markers, as luminal A tumors [estrogen and/or progesterone receptors (ER/PE) positive and Her-2 negative]; luminal B tumors (ER/PR positive and Her-2 positive);Her-2 positive tumors (ER/PR negative with Her-2 positive); and triple negative phenotype (all markers negative).Results: In our series, 116 patients had tumors of luminal A type (47.93%); 67 (27.68%) were luminal type B; 33(13.63%) were Her2 positive; and 26 (10.74%) were triple negative.The recurrence rate was 19% for luminal type A tumors, 25.4% for luminal type B, 39.4% for Her2 positive and30.8% for triple negative lesions.The mean relapse free survival was 79.07, 73.07, 64.3 and 83,5 months for luminal A and B, Her-2 and triple negative lesions, respectively.Mortality rate reached 11.2% for luminal A tumors compared with 19.4, 33.3 and 26.9% for luminal B, Her2 and triple negative tumors, respectively.The mean overall survival for these groups was 88.42, 81.41, 77.62 and 93.6months.Conclusion: Molecular classifcation with immunohistochemistry behaves as a significant prognosticator for breast invasive ductal carcinoma in our series of patients.The worse prognosis observed for Her2 expressing lesions may have changed after trastuzumab use.
其他文献
Introduction: HER-2 overexpression, a predictive marker of tumor aggressiveness and responsiveness to therapy,occurs in 20-30% of breast cancer.Although breast cancer is a heterogeneous disease, HER-2
The decision to treat breast cancer patients with Trastuzumab is based on HER2 receptor over-expression or gene amplification.However, even in this selective group of patients, the response rate remai
Background: The prognosis of approximately 60% of the breast cancer patients depends on the local treatment alone.Breast conserving therapy has been proved to be as good as mastectomy for breast cance
There is an urgent need for cost-effective, noninvasive diagnostic techniques for the evaluation of breast lesions.While contrast-enhanced magnetic resonance imaging (MRI) now provide very high sensit
Purpose: Breast cancer is the most common female malignancy in Taiwan; quality of life following breast cancer therapy, though, remains rarely addressed.The aim is to evaluate quality of life among Ta
IGF-1 is essential for normal mammary gland development but also associated with premenopausal breast cancer risk.Combined oral contraceptives (OCs) decrease the IGF-1 levels in most women.The endogen
[Purpose] Endocrine ductal carcinoma in situ (E-DCIS) is an intraductal carcinoma characterized by endocrine features and expression of neuroendocrine markers.E-DCIS and intraductal papilloma (IDP) re
Histologic grade is a well-established prognostic factor for breast cancer.Many trials and studies had proven its role and significance in Caucasian women.However, the relationships among histologic g
Background: Breast carcinoma is the commonest cancer among Singaporean women.Syndecan-1 is a transmembrane heparan sulphate proteoglycan.Previous studies have shown that heparan sulphate is overexpres
Spontaneous canine inflammatory mammary cancer (IMC) shares epidemiologic, histopathological and clinical characteristics with the disease in humans and thereby it has proposed as a natural model for